BridgeBio Pharma (BBIO) Net Margin (2019 - 2026)
BridgeBio Pharma (BBIO) reported Net Margin of 84.33% for Q1 2026, up 5921.0% on a YoY basis from 1.4% in Q1 2025, and up 32.58% sequentially from 125.09% in Q4 2025.
BridgeBio Pharma (BBIO) Net Margin (2019 - 2026) Analysis & Trends
BridgeBio Pharma (BBIO) has 8 years of Net Margin data on file, last reported at 84.33% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin rose 5921.0% year-over-year to 84.33%; the trailing twelve-month figure through Mar 2026 stood at 124.41% (up 39983.0% YoY), and the FY2025 full-year result was 144.39%, up 9705.0% from the prior year.
- Net Margin climbed to 84.33% in Q1 2026, from 125.09% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 13.36% in Q2 2022 to a low of 40632.84% in Q3 2022.
- A 5-year average of 6198.18% and a median of 4326.55% in 2023 frame the typical range for Net Margin.
- Across the five-year window, Net Margin plunged 3398032 bps in 2022 and surged 3630629 bps in 2023, its largest moves.
- Tracing BBIO's Net Margin over 5 years: stood at 7357.81% in 2022, then slumped by 31 bps to 9635.99% in 2023, then soared by 53 bps to 4506.12% in 2024, then soared by 97 bps to 125.09% in 2025, then jumped by 33 bps to 84.33% in 2026.
- Business Quant data shows BBIO's Net Margin at 84.33% in Q1 2026, 125.09% in Q4 2025, and 151.4% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | BridgeBio Pharma | 16.15 Bn | 15.22 Bn | 184.58 Mn | -84.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -84.33% |
| Dec 31, 2025 | -125.09% |
| Sep 30, 2025 | -151.40% |
| Jun 30, 2025 | -164.52% |
| Mar 31, 2025 | -143.55% |
| Dec 31, 2024 | -4,506.12% |
| Sep 30, 2024 | -5,931.19% |
| Jun 30, 2024 | -3,388.19% |
| Mar 31, 2024 | -16.68% |
| Dec 31, 2023 | -9,635.99% |
| Sep 30, 2023 | -4,326.55% |
| Jun 30, 2023 | -9,622.12% |
| Mar 31, 2023 | -7,675.58% |
| Dec 31, 2022 | -7,357.81% |
| Sep 30, 2022 | -40,632.84% |
| Jun 30, 2022 | -13.36% |
| Mar 31, 2022 | -11,593.68% |
| Dec 31, 2021 | -1,471.77% |
| Sep 30, 2021 | -6,652.52% |
| Jun 30, 2021 | -178.34% |